295 related articles for article (PubMed ID: 19252950)
1. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
[TBL] [Abstract][Full Text] [Related]
2. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Sommariva A; Evangelista L; Pintacuda G; Cervino AR; Ramondo G; Rossi CR
Abdom Radiol (NY); 2018 May; 43(5):1094-1100. PubMed ID: 28770289
[TBL] [Abstract][Full Text] [Related]
4. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
[TBL] [Abstract][Full Text] [Related]
5. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
[TBL] [Abstract][Full Text] [Related]
6. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
De Vos N; Goethals I; Ceelen W
Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
Audollent R; Eveno C; Dohan A; Sarda L; Jouvin I; Soyer P; Pocard M
J Visc Surg; 2015 Nov; 152(5):285-91. PubMed ID: 26115889
[TBL] [Abstract][Full Text] [Related]
10. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
Klumpp BD; Schwenzer N; Aschoff P; Miller S; Kramer U; Claussen CD; Bruecher B; Koenigsrainer A; Pfannenberg C
Abdom Imaging; 2013 Feb; 38(1):64-71. PubMed ID: 22476333
[TBL] [Abstract][Full Text] [Related]
11. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.
Pasqual EM; Bertozzi S; Bacchetti S; Londero AP; Basso SM; Santeufemia DA; Lo Re G; Lumachi F
Anticancer Res; 2014 May; 34(5):2363-8. PubMed ID: 24778044
[TBL] [Abstract][Full Text] [Related]
12. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
de Bree E; Koops W; Kröger R; van Ruth S; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2006 Feb; 32(1):65-71. PubMed ID: 16290055
[TBL] [Abstract][Full Text] [Related]
13. Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.
Berthelot C; Morel O; Girault S; Verrièle V; Poirier AL; Moroch J; Boucher Y; Le Jeune JJ; Lorimier G
Nucl Med Commun; 2011 Jan; 32(1):23-9. PubMed ID: 21042225
[TBL] [Abstract][Full Text] [Related]
14. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
[TBL] [Abstract][Full Text] [Related]
16. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
[TBL] [Abstract][Full Text] [Related]
17. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
18. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal Cancer Index by (18)F-FDG PET/TC pre and post-hyperthermic intraperitoneal chemotherapy. Report of a case.
Garcia JR; Villasboas-Rosciolesi D; Soler M; Bassa P; Cozar M; Riera E
Rev Esp Med Nucl Imagen Mol; 2016; 35(5):329-31. PubMed ID: 27036888
[TBL] [Abstract][Full Text] [Related]
20. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
